Pulsed field ablation vs. medical therapy for atrial fibrillation: a propensity score–matched comparison with the JoFib registry
Abdalrahman Al-slaimieh, Khaled A. Abukhalaf, Nour S. Haj Ali, Jude Awad, Abdallah Al-Ani, Ayman J. Hammoudeh, Mohammad Hajjiri · 2026
Read Pulsed field ablation vs. medical therapy for atrial fibrillation: a propensity score–matched comparison with the JoFib registry by Abdalrahman Al-slaimieh, Khaled A. Abukhalaf, Nour S. Haj Ali, Jude Awad, Abdallah Al-Ani, Ayman J. Hammoudeh, Mohammad Hajjiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278897.txt.
Description
Abdalrahman Al-slaimieh and colleagues compare pulsed field ablation with drug therapy for atrial fibrillation in a 2026 study. The ablation method uses electric pulses rather than heat to quiet faulty heart tissue. Their report is among the earliest on this technique from the Middle East and North Africa region.
Sixty-two ablated patients were matched against sixty-two registry patients treated with medicines alone. Groups were balanced on age, heart size, risk scores, and prior drug use. Readmissions for rhythm relapse or heart failure were far lower after ablation at both one and six months. Freedom from readmission also favoured ablation strongly. The authors call for larger regional studies to confirm the early signal.
Catalog record
| CREATOR | Abdalrahman Al-slaimieh, Khaled A. Abukhalaf, Nour S. Haj Ali, Jude Awad, Abdallah Al-Ani, Ayman J. Hammoudeh, Mohammad Hajjiri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |